SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2796-2809

  Watson, Neva B ^a   Schneider, Karin M ^a   Massa, Paul T ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIBODY; CLODRONIC ACID; LYMPHOCYTE ANTIBODY; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG; CD47 ANTIGEN; NEUTRALIZING ANTIBODY; PTPN6 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; INNATE IMMUNITY; MACROPHAGE; MOBILIZATION; MONOCYTE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; MUSCLE ATROPHY; MUSCLE CELL; MUSCULAR DYSTROPHY; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; VIRUS INDUCED MYOSITIS; ANIMAL; C3H MOUSE; C57BL MOUSE; CARDIOVIRUS INFECTION; DEFICIENCY; DNA MICROARRAY; DRUG EFFECTS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; THEILOVIRUS; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD47; CARDIOVIRUS INFECTIONS; CELL DIFFERENTIATION; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MONOCYTES; MUSCLE, SKELETAL; MYOSITIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; THEILOVIRUS; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 84924565869     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402210     Document Type: Article

References (91)

1. Crum-Cianflone, N. F. 2008. Bacterial, fungal, parasitic, and viral myositis. Clin. Microbiol. Rev. 21: 473-494.
2. Josselson, J., T. Pula, and J. H. Sadler. 1980. Acute rhabdomyolysis associated with an echovirus 9 infection. Arch. Intern. Med. 140: 1671-1672.
3. Jehn, U. W., and M. K. Fink. 1980. Myositis, myoglobinemia, and myoglobinuria associated with enterovirus echo 9 infection. Arch. Neurol. 37: 457-458.
4. Dunnet, J., J. Y. Paton, and C. E. Robertson. 1981. Acute renal failure and Coxsackie viral infection. Clin. Nephrol. 16: 262-263.
5. Chariot, P., E. Ruet, F. J. Authier, Y. Lévy, and R. Gherardi. 1994. Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 44: 1692-1696.
6. Dalakas, M. C., G. H. Pezeshkpour, M. Gravell, and J. L. Sever. 1986. Polymyositis associated with AIDS retrovirus. JAMA 256: 2381-2383.
7. Leon-Monzon, M., I. Illa, and M. C. Dalakas. 1994. Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease. Ann. Neurol. 36: 643-649.
8. Morgan, O. S., P. Rodgers-Johnson, C. Mora, and G. Char. 1989. HTLV-1 and polymyositis in Jamaica. Lancet 2: 1184-1187.
9. Nishikai, M., and A. Sato. 1991. Human T lymphotropic virus type I and polymyositis and dermatomyositis in Japan. Arthritis Rheum. 34: 791-792.
10. Di Muzio, A., B. Bonetti, M. Capasso, L. Panzeri, E. Pizzigallo, N. Rizzuto, and A. Uncini. 2003. Hepatitis C virus infection and myositis: a virus localization study. Neuromuscul. Disord. 13: 68-71.
11. Mihas, A. A., J. D. Kirby, and S. P. Kent. 1978. Hepatitis B antigen and polymyositis. JAMA 239: 221-222.
12. Nojima, T., M. Hirakata, S. Sato, T. Fujii, A. Suwa, T. Mimori, and Y. Ikeda. 2000. A case of polymyositis associated with hepatitis B infection. Clin. Exp. Rheumatol. 18: 86-88.
13. Chopy, D., C. N. Detje, M. Lafage, U. Kalinke, and M. Lafon. 2011. The type I interferon response bridles rabies virus infection and reduces pathogenicity. J. Neurovirol. 17: 353-367.
14. Tsiang, H. 1988. Rabies virus infection of myotubes and neurons as elements of the neuromuscular junction. Rev. Infect. Dis. 10(Suppl. 4): S733-S738.
15. Park, C. H., M. Kondo, S. Inoue, A. Noguchi, T. Oyamada, H. Yoshikawa, and A. Yamada. 2006. The histopathogenesis of paralytic rabies in six-week-old C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle. J. Vet. Med. Sci. 68: 589-595.
16. Bachis, A., S. A. Aden, R. L. Nosheny, P. M. Andrews, and I. Mocchetti. 2006. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. J. Neurosci. 26: 6771-6780.
17. Shindler, K. S., D. Chatterjee, K. Biswas, A. Goyal, M. Dutt, M. Nassrallah, R. S. Khan, and J. Das Sarma. 2011. Macrophage-mediated optic neuritis induced by retrograde axonal transport of spike gene recombinant mouse hepatitis virus. J. Neuropathol. Exp. Neurol. 70: 470-480.
18. Ahmed, F., L. MacArthur, M. A. De Bernardi, and I. Mocchetti. 2009. Retrograde and anterograde transport of HIV protein gp120 in the nervous system. Brain Behav. Immun. 23: 355-364.
19. Mori, I., and Y. Kimura. 2001. Neuropathogenesis of influenza virus infection in mice. Microbes Infect. 3: 475-479.
20. Das Sarma, J., L. C. Kenyon, S. T. Hingley, and K. S. Shindler. 2009. Mechanisms of primary axonal damage in a viral model of multiple sclerosis. J. Neurosci. 29: 10272-10280.
21. Centers for Disease Control and Prevention (CDC). 2013. West Nile virus and other arboviral diseases-United States, 2012. MMWR Morb. Mortal. Wkly. Rep. 62: 513-517.
22. Lidbury, B. A., C. Simeonovic, G. E. Maxwell, I. D. Marshall, and A. J. Hapel. 2000. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J. Infect. Dis. 181: 27-34.
23. Herrero, L. J., M. Nelson, A. Srikiatkhachorn, R. Gu, S. Anantapreecha, G. Fingerle-Rowson, R. Bucala, E. Morand, L. L. Santos, and S. Mahalingam. 2011. Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. Proc. Natl. Acad. Sci. USA 108: 12048-12053.
24. Morrison, T. E., A. C. Whitmore, R. S. Shabman, B. A. Lidbury, S. Mahalingam, and M. T. Heise. 2006. Characterization of Ross River virus tropism and virusinduced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80: 737-749.
25. Harley, D., D. Bossingham, D. M. Purdie, N. Pandeya, and A. C. Sleigh. 2002. Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med. J. Aust. 177: 352-355.
26. Seay, A. R., and J. S. Wolinsky. 1982. Ross River virus-induced demyelination: I. Pathogenesis and histopathology. Ann. Neurol. 12: 380-389.
27. Sane, J., S. Kurkela, M. Desdouits, H. Kalimo, S. Mazalrey, M. L. Lokki, A. Vaheri, T. Helve, J. Törnwall, M. Huerre, et al. 2012. Prolonged myalgia in Sindbis virus infection: case description and in vitro infection of myotubes and myoblasts. J. Infect. Dis. 206: 407-414.
28. Kurkela, S., T. Manni, J. Myllynen, A. Vaheri, and O. Vapalahti. 2005. Clinical and laboratory manifestations of Sindbis virus infection: prospective study, Finland, 2002-2003. J. Infect. Dis. 191: 1820-1829.
29. Assunção-Miranda, I., C. Cruz-Oliveira, and A. T. Da Poian. 2013. Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis. Biomed Res. Int. 2013: 973516. 1155/2013/973516.
30. Couderc, T., F. Chrétien, C. Schilte, O. Disson, M. Brigitte, F. Guivel-Benhassine, Y. Touret, G. Barau, N. Cayet, I. Schuffenecker, et al. 2008. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 4: e29.
31. Rohatgi, A., J. C. Corbo, K. Monte, S. Higgs, D. L. Vanlandingham, G. Kardon, and D. J. Lenschow. 2014. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. J. Virol. 88: 2414-2425.
32. Carod-Artal, F. J., O. Wichmann, J. Farrar, and J. Gascón. 2013. Neurological complications of dengue virus infection. Lancet Neurol. 12: 906-919.
33. Rajajee, S., S. Ezhilarasi, and K. Rajarajan. 2005. Benign acute childhood myositis. Indian J. Pediatr. 72: 399-400.
34. Finsterer, J., and K. Kongchan. 2006. Severe, persisting, steroid-responsive Dengue myositis. J. Clin. Virol. 35: 426-428.
35. Paliwal, V. K., R. K. Garg, R. Juyal, N. Husain, R. Verma, P. K. Sharma, R. Verma, and M. K. Singh. 2011. Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis. J. Neurol. Sci. 300: 14-18.
36. Oleszak, E. L., J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas. 2004. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 17: 174-207.
37. Rustigian, R., A. M. Pappenheimer, and T. LeBLANC. 1951. The resistance of mice to myositis and central nervous system infection following immunization with DGVII mouse encephalomyelitis virus. J. Immunol. 67: 225-234.
38. Rustigian, R., and A. M. Pappenheimer. 1949. Myositis in mice following intramuscular injection of viruses of the mouse encephalomyelitis group and of certain other neurotropic viruses. J. Exp. Med. 89: 69-92.
39. Gómez, R. M., J. E. Rinehart, R. Wollmann, and R. P. Roos. 1996. Theiler's murine encephalomyelitis virus-induced cardiac and skeletal muscle disease. J. Virol. 70: 8926-8933.
40. Christophi, G. P., and P. T. Massa. 2009. Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. Viral Immunol. 22: 371-387.
41. Christophi, G. P., C. A. Hudson, M. Panos, R. C. Gruber, and P. T. Massa. 2009. Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease. J. Virol. 83: 522-539.
42. Massa, P. T., S. L. Ropka, S. Saha, K. L. Fecenko, and K. L. Beuler. 2002. Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus. J. Virol. 76: 8335-8346.
43. Chong, Z. Z., and K. Maiese. 2007. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol. Histopathol. 22: 1251-1267.
44. Zhang, J., A. K. Somani, and K. A. Siminovitch. 2000. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12: 361-378.
45. Croker, B. A., B. R. Lawson, S. Rutschmann, M. Berger, C. Eidenschenk, A. L. Blasius, E. M. Moresco, S. Sovath, L. Cengia, L. D. Shultz, et al. 2008. Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc. Natl. Acad. Sci. USA 105: 15028-15033.
46. Okazawa, H., S. Motegi, N. Ohyama, H. Ohnishi, T. Tomizawa, Y. Kaneko, P. A. Oldenborg, O. Ishikawa, and T. Matozaki. 2005. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J. Immunol. 174: 2004-2011.
47. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
48. Crane, M. J., J. M. Daley, O. van Houtte, S. K. Brancato, W. L. Henry, Jr., and J. E. Albina. 2014. The monocyte to macrophage transition in the murine sterile wound. PLoS ONE 9: e86660.
49. Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
50. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
51. Matozaki, T., Y. Murata, H. Okazawa, and H. Ohnishi. 2009. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 19: 72-80.
52. Oldenborg, P. A. 2013. CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease. ISRN Hematol. 2013: 614619.
53. Toledano, N., D. Gur-Wahnon, A. Ben-Yehuda, and J. Rachmilewitz. 2013. Novel CD47: SIRPa dependent mechanism for the activation of STAT3 in antigen-presenting cell. PLoS ONE 8: e75595.
54. Azcutia, V., M. Stefanidakis, N. Tsuboi, T. Mayadas, K. J. Croce, D. Fukuda, M. Aikawa, G. Newton, and F. W. Luscinskas. 2012. Endothelial CD47 promotes vascular endothelial-cadherin tyrosine phosphorylation and participates in T cell recruitment at sites of inflammation in vivo. J. Immunol. 189: 2553-2562.
55. Han, M. H., D. H. Lundgren, S. Jaiswal, M. Chao, K. L. Graham, C. S. Garris, R. C. Axtell, P. P. Ho, C. B. Lock, J. I. Woodard, et al. 2012. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J. Exp. Med. 209: 1325-1334.
56. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
57. Ramachandran, P., A. Pellicoro, M. A. Vernon, L. Boulter, R. L. Aucott, A. Ali, S. N. Hartland, V. K. Snowdon, A. Cappon, T. T. Gordon-Walker, et al. 2012. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. USA 109: E3186-E3195.
58. Villalta, S. A., C. Rinaldi, B. Deng, G. Liu, B. Fedor, and J. G. Tidball. 2011. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet. 20: 790-805.
59. Jelachich, M. L., P. Bandyopadhyay, K. Blum, and H. L. Lipton. 1995. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 209: 437-444.
60. Jelachich, M. L., H. V. Reddi, M. D. Trottier, B. P. Schlitt, and H. L. Lipton. 2004. Susceptibility of peritoneal macrophages to infection by Theiler's virus. Virus Res. 104: 123-127.
61. Jelachich, M. L., C. Bramlage, and H. L. Lipton. 1999. Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis. J. Virol. 73: 3227-3235.
62. Li, Q., and J. Uitto. 2013. Mineralization/anti-mineralization networks in the skin and vascular connective tissues. Am. J. Pathol. 183: 10-18.
63. Leone, A., A. M. Costantini, R. Brigida, O. M. Antoniol, R. Antonelli-Incalzi, and L. Bonomo. 2005. Soft-tissue mineralization in Werner syndrome. Skeletal Radiol. 34: 47-51.
64. Giachelli, C. M. 1999. Ectopic calcification: gathering hard facts about soft tissue mineralization. Am. J. Pathol. 154: 671-675.
65. Mizunoya, W., R. Upadhaya, F. J. Burczynski, G. Wang, and J. E. Anderson. 2011. Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm. Am. J. Physiol. Cell Physiol. 300: C1065-C1077.
66. Verma, M., Y. Asakura, H. Hirai, S. Watanabe, C. Tastad, G. H. Fong, M. Ema, J. A. Call, D. A. Lowe, and A. Asakura. 2010. Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum. Mol. Genet. 19: 4145-4159.
67. Pajak, B., S. Orzechowska, B. Pijet, M. Pijet, A. Pogorzelska, B. Gajkowska, and A. Orzechowski. 2008. Crossroads of cytokine signaling-the chase to stop muscle cachexia. J. Physiol. Pharmacol. 59(Suppl. 9): 251-264.
68. Sharma, R., and S. D. Anker. 2002. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int. J. Cardiol. 85: 161-171.
69. Schmidt, J., K. Barthel, J. Zschüntzsch, I. E. Muth, E. J. Swindle, A. Hombach, S. Sehmisch, A. Wrede, F. Lühder, R. Gold, and M. C. Dalakas. 2012. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1b-induced accumulation of b-amyloid and cell death. Brain 135: 1102-1114.
70. Chattergoon, M. A., R. Latanich, J. Quinn, M. E. Winter, R. W. Buckheit, III, J. N. Blankson, D. Pardoll, and A. L. Cox. 2014. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 10: e1004082.
71. Guo, H., J. Gao, D. J. Taxman, J. P. Ting, and L. Su. 2014. HIV-1 infection induces interleukin-1b production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J. Biol. Chem. 289: 21716-21726.
72. Schlaepfer, E., M. A. Rochat, L. Duo, and R. F. Speck. 2014. Triggering TLR2,-3,-4,-5, and-8 reinforces the restrictive nature of M1-and M2-polarized macrophages to HIV. J. Virol. 88: 9769-9781.
73. Herbein, G., and A. Varin. 2010. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7: 33.
74. Alhoot, M. A., S. M. Wang, and S. D. Sekaran. 2011. Inhibition of dengue virus entry and multiplication into monocytes using RNA interference. PLoS Negl. Trop. Dis. 5: e1410.
75. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11(Suppl. 4): S830-S839.
76. O'Sullivan, M. A., and H. M. Killen. 1994. The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus. J. Gen. Virol. 75: 2387-2392.
77. Chen, Y. C., S. Y. Wang, and C. C. King. 1999. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J. Virol. 73: 2650-2657.
78. Ahmed, S., F. Arif, Y. Yahya, A. Rehman, K. Abbas, S. Ashraf, and D. S. Akram. 2008. Dengue fever outbreak in Karachi 2006-a study of profile and outcome of children under 15 years of age. J. Pak. Med. Assoc. 58: 4-8.
79. Pham, A. M., R. A. Langlois, and B. R. TenOever. 2012. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog. 8: e1002465.
80. Perry, S. T., M. D. Buck, S. M. Lada, C. Schindler, and S. Shresta. 2011. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 7: e1001297.
81. Sun, P., and T. J. Kochel. 2013. The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis. Sci. World J. 2013: 843469. 1155/2013/843469.
82. Zhou, D., C. A. Collins, P.Wu, and E. J. Brown. 2010. Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase. J. Leukoc. Biol. 87: 845-855.
83. Rayavarapu, S., W. Coley, T. B. Kinder, and K. Nagaraju. 2013. Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skeletal Muscle 3: 13.
84. Stoermer, K. A., A. Burrack, L. Oko, S. A. Montgomery, L. B. Borst, R. G. Gill, and T. E. Morrison. 2012. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J. Immunol. 189: 4047-4059.
85. Uchiyama, T., K. Arai, T. Yamamoto-Tabata, K. Hirai, K. Kishimoto, Y. Nakamura, and T. Hattori. 2005. Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection. J. Neurol. 252: 519-525.
86. Rothwell, S., R. G. Cooper, J. A. Lamb, and H. Chinoy. 2013. Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 25: 735-741.
87. Lazarou, I. N., and P. A. Guerne. 2013. Classification, diagnosis, and management of idiopathic inflammatory myopathies. J. Rheumatol. 40: 550-564.
88. Gan, L., and F. W. Miller. 2011. State of the art: what we know about infectious agents and myositis. Curr. Opin. Rheumatol. 23: 585-594.
89. Son, K. N., Z. Liang, and H. L. Lipton. 2013. Mutation of the Theiler's virus leader protein zinc-finger domain impairs apoptotic activity in murine macrophages. Virus Res. 177: 222-225.
90. Jelachich, M. L., and H. L. Lipton. 1999. Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis. J. Gen. Virol. 80: 1701-1705.
91. Jelachich, M. L., and H. L. Lipton. 2001. Theiler's murine encephalomyelitis virus induces apoptosis in gamma interferon-activated M1 differentiated myelomonocytic cells through a mechanism involving tumor necrosis factor alpha (TNF-alpha) and TNF-alpha-related apoptosis-inducing ligand. J. Virol. 75: 5930-5938.